GLD Partners has secured access to Heligenics’ GigaAssay platform to launch Altagenics, a startup with ambitions to develop first-in-class medicines for muscle-wasting conditions. 

Read the article at https://www.fiercebiotech.com/biotech/gld-flexes-muscle-wasting-ambitions-launching-altagenics-assist-heligenics